New Variant in NYC; Moderna, Pfizer Target New Variants; NDA for Presbyopia Drug thumbnail

New Variant in NYC; Moderna, Pfizer Target New Variants; NDA for Presbyopia Drug

Note that some links may require registration or subscription.

A new coronavirus variant, B.1.526, is spreading in New York City. (New York Times)

Moderna said it sent a new COVID-19 vaccine targeting variant B.1.351 to the NIH for clinical testing.

Pfizer/BioNTech will also test a third dose of its injection to provide better protection against emerging variants. (STAT)

As of 8 a.m. ET on Thursday, the unofficial COVID-19 toll in the U.S. included 28,336,566 cases and 505,899 deaths, up 74,932 and 3,218, respectively, since the same time Wednesday.

The FDA warned against compounding remdesivir for COVID-19 because of “complexities related to the quality and sourcing” of the active ingredient; and pharmacies shouldn’t produce thymosin alpha-1 for COVID, either, because it’s not approved at all.

During the pandemic more teens have gone to the hospital for mental health care, with rates of suicidal thinking and behavior up 25% from last year in this age group. (New York Times)

Scammers posing as Pfizer and Moderna have created sham websites to trick people into buying COVID shots online. (Wall Street Journal)

One Medical, the national concierge healthcare provider, vaccinated ineligible members. (NPR)

German Chancellor Angela Merkel warned of a potential third wave in the country due to COVID-19 variants. (Reuters)

In the U.K., meanwhile, officials said people might not have to wear masks during the summer, though resumption in the fall could be necessary. (Reuters)

Britain’s national medical director criticized Gwyneth Paltrow’s high-priced treatment for long COVID, stating that “serious science” should be applied. (BBC News)

In related news, the WHO agreed that long COVID is a serious matter. (Reuters)

In other news:

  • Amanda D’Ambrosio is a reporter on MedPage Today’s enterprise & investigative team. She covers obstetrics-gynecology and other clinical news, and writes features about the U.S. healthcare system. Follow

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *